Conditions: Age - Related Macular Degeneration (AMD)
Keywords: AMD
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 154
Healthy volunteers: no

Brief summary:
This is a phase 4, open-label, single arm, multicenter, clinical study in patients with neovascular AMD designed to evaluate the efficacy and safety of Intravitreal Aflibercept Injection (IAI) administered over 2 years , and to provide clinical information from the first year in the trial evaluating the adverse effects, if any, on the corneal endothelium following administration of IAI.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Intravitreal Aflibercept Injection (IAI)
Intervention descriptions: intervention 1: None

Protocol document: